Tuberculosis Prophylaxis With Levofloxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis: Safety Analysis of a Multicenter Randomized Trial

Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009–2012

(2014) S. Bamrah et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Levofloxacin for BK Virus Prophylaxis Following Kidney Transplantation

(2014) Greg A. Knoll et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risks associated with the therapeutic use of fluoroquinolones

(2013) Ralf Stahlmann et al.   Expert Opinion On Drug Safety

Strategies for Treating Latent Multiple-Drug Resistant Tuberculosis: A Decision Analysis

(2012) David P. Holland et al.   PLoS One

Synergistic effects of dexamethasone and quinolones on human-derived tendon cells

(2010) Judith Sendzik et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

(2010) Kenneth F Schulz et al.   Trials

Safety of Fluoroquinolone Use in Patients with Hepatotoxicity Induced by Anti‐Tuberculosis Regimens

(2009) Chao‐Chi Ho et al.   CLINICAL INFECTIOUS DISEASES

Tuberculosis after Solid‐Organ Transplant: Incidence, Risk Factors, and Clinical Characteristics in the RESITRA (Spanish Network of Infection in Transplantation) Cohort

(2009) Julián Torre‐Cisneros et al.   CLINICAL INFECTIOUS DISEASES

Tuberculosis in Solid‐Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology

(2009) José María Aguado et al.   CLINICAL INFECTIOUS DISEASES

Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data

(2008) Judith Sendzik et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS